ATE517986T1 - Enzymatische umwandlung von roten blutzellen der blutgruppen b und ab unter verwendung von einem alpha-galactosidase mit einzigartigen substratspezifitäten und kinetischen eigenschaften - Google Patents

Enzymatische umwandlung von roten blutzellen der blutgruppen b und ab unter verwendung von einem alpha-galactosidase mit einzigartigen substratspezifitäten und kinetischen eigenschaften

Info

Publication number
ATE517986T1
ATE517986T1 AT02763720T AT02763720T ATE517986T1 AT E517986 T1 ATE517986 T1 AT E517986T1 AT 02763720 T AT02763720 T AT 02763720T AT 02763720 T AT02763720 T AT 02763720T AT E517986 T1 ATE517986 T1 AT E517986T1
Authority
AT
Austria
Prior art keywords
galactosidase
alpha
blood group
enzymatic conversion
substrate specificities
Prior art date
Application number
AT02763720T
Other languages
English (en)
Inventor
Henrik Clausen
La Vega Humberto De
Cheryl Hill
Qiyong Liu
Original Assignee
Velico Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Velico Medical Inc filed Critical Velico Medical Inc
Application granted granted Critical
Publication of ATE517986T1 publication Critical patent/ATE517986T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0641—Erythrocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2465—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1) acting on alpha-galactose-glycoside bonds, e.g. alpha-galactosidase (3.2.1.22)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01022—Alpha-galactosidase (3.2.1.22)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01049—Alpha-N-acetylgalactosaminidase (3.2.1.49)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AT02763720T 2001-09-25 2002-09-25 Enzymatische umwandlung von roten blutzellen der blutgruppen b und ab unter verwendung von einem alpha-galactosidase mit einzigartigen substratspezifitäten und kinetischen eigenschaften ATE517986T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US32497001P 2001-09-25 2001-09-25
US36176902P 2002-03-05 2002-03-05
US10/251,271 US7767415B2 (en) 2001-09-25 2002-09-20 Compositions and methods for modifying blood cell carbohydrates
PCT/US2002/030403 WO2003027245A2 (en) 2001-09-25 2002-09-25 CONVERSION OF RED BLOOD CELLS A, B, AND AB USING a-N-ACETYLGALACTOSAMINIDASES AND a-GALACTOSIDASE

Publications (1)

Publication Number Publication Date
ATE517986T1 true ATE517986T1 (de) 2011-08-15

Family

ID=27400431

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02763720T ATE517986T1 (de) 2001-09-25 2002-09-25 Enzymatische umwandlung von roten blutzellen der blutgruppen b und ab unter verwendung von einem alpha-galactosidase mit einzigartigen substratspezifitäten und kinetischen eigenschaften

Country Status (7)

Country Link
US (5) US7767415B2 (de)
EP (2) EP1436387B1 (de)
JP (2) JP4371810B2 (de)
AT (1) ATE517986T1 (de)
AU (1) AU2008203095B2 (de)
CA (1) CA2460575C (de)
WO (1) WO2003027245A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7767415B2 (en) * 2001-09-25 2010-08-03 Velico Medical, Inc. Compositions and methods for modifying blood cell carbohydrates
EA011481B1 (ru) * 2003-02-17 2009-04-28 Коуд Биотек Лимитид Эритроциты, имеющие ферментативно уменьшенный уровень экспрессии антигена группы крови системы аво, способ их получения и применение
US20070287196A1 (en) * 2004-06-11 2007-12-13 Adeka Corporation Enzymatic Modification of Cell-Surface H Antigen by Glycosyltransferases
AU2006272675B2 (en) * 2005-07-26 2012-07-05 Velico Medical, Inc. Blood processing device and associated systems and methods
US20070100557A1 (en) * 2005-10-24 2007-05-03 Yi Zhang Selection of genotyped transfusion donors by cross-matching to genotyped recipients
EP1945269A4 (de) * 2005-10-31 2010-02-17 Zymequest Inc Neue a-galactosidasen
EP2502494A3 (de) * 2005-10-31 2012-12-19 Velico Medical, Inc. Neue a-galactosidasen
US20080207983A1 (en) * 2007-02-22 2008-08-28 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Coded-sequence activation of surgical implants
WO2008136735A1 (en) 2007-05-04 2008-11-13 Nilsson Kurt G I Material for separation of a biomolecule
CN100569942C (zh) * 2007-11-02 2009-12-16 中国人民解放军军事医学科学院野战输血研究所 一种α-N-乙酰半乳糖胺酶及其编码基因与应用
GB0817908D0 (en) 2008-10-01 2008-11-05 Univ Ghent Blood group a/b/h determinant on type 1 core glycosphinglipids chain as recognition point for the fedf protein of f18-fimbriated enterotoxigenic
US9095436B2 (en) 2009-04-14 2015-08-04 The Invention Science Fund I, Llc Adjustable orthopedic implant and method for treating an orthopedic condition in a subject
US9788539B2 (en) 2011-05-17 2017-10-17 Velico Medical, Inc. Platelet protection solution having beta-galactosidase and sialidase inhibitors
CA2887083A1 (en) 2012-10-05 2014-04-10 Velico Medical, Inc. Platelet additive solution having a beta-galactosidase inhibitor
EP3837370A4 (de) * 2018-08-17 2022-09-14 The University of British Columbia Enzymatische zusammensetzungen zur spaltung von kohlenhydratantigen, verfahren, verwendungen, vorrichtungen und damit assoziierte systeme

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4209509A (en) * 1978-02-08 1980-06-24 Meiji Seika Kaisha Ltd. Substance SF-1739 derivatives, process for preparing the same and antibacterial compositions containing the same
US4330619A (en) 1980-08-14 1982-05-18 New York Blood Center, Inc. Enzymatic conversion of red cells for transfusion
US4427777A (en) 1980-08-14 1984-01-24 New York Blood Center, Inc. Enzymatic conversion of red cells for transfusion
US4609627A (en) * 1983-08-01 1986-09-02 New York Blood Center, Inc. Enzymatic conversion of certain sub-type A and AB erythrocytes
CA1339101C (en) 1986-06-03 1997-07-29 Nicolaas Overbeeke Production of guar alpha-galactosidase and immunologically related alpha-galactosidases by host organisms transformed with recombinant dna methods
US5382524A (en) 1990-10-24 1995-01-17 The Mount Sinai School Of Medicine Of The City University Of New York Cloning and expression of biologically active α-n-acetylgalactosaminidase
US5401650A (en) 1990-10-24 1995-03-28 The Mount Sinai School Of Medicine Of The City University Of New York Cloning and expression of biologically active α-galactosidase A
WO1994009121A1 (en) 1992-10-22 1994-04-28 The New York Blood Center, Inc. Preparation of enzyme for conversion of sub-type a and ab erythrocytes
WO1994009123A1 (en) 1992-10-22 1994-04-28 The New York Blood Center, Inc. Recycling of enzymes used to convert sub-type a, b and ab erythrocytes
US6228631B1 (en) 1992-10-22 2001-05-08 New York Blood Center, Inc. Recombinant α-N-acetylgalactosaminidase enzyme and cDNA encoding said enzyme
JPH06285701A (ja) 1993-04-05 1994-10-11 Fanuc Ltd Ｎｃ旋削加工装置
US6329191B1 (en) 1993-08-30 2001-12-11 Hawaii Biotechnology Group, Inc. DNA encoding recombinant coffee bean alpha-galactosidase
US6458573B1 (en) 1993-09-23 2002-10-01 New England Biolabs, Inc. Isolation and composition of a novel glycosidase from chryseobacterium
US5633130A (en) 1994-09-08 1997-05-27 The Curators Of The University Of Missouri Buffer system for increasing seroconversion efficiency
US5606042A (en) 1994-09-08 1997-02-25 The Curators Of The University Of Missouri Glycine α-D-galactosidases
US6423525B1 (en) 1994-09-22 2002-07-23 New England Biolabs, Inc. Isolation and composition of a novel glycosidase from chryseobacterium
JPH10513057A (ja) 1995-01-30 1998-12-15 ニューヨーク・ブラッド・センター・インコーポレイテッド 組換えα−ガラクトシダーゼ酵素
US6184017B1 (en) 1996-05-08 2001-02-06 The Curators Of The University Of Missouri Glycine and phaseolus α-D-galactosidases
US5925541A (en) 1996-09-11 1999-07-20 New York Blood Center, Inc. Endo-β-galactosidase
JP2001505563A (ja) * 1996-11-21 2001-04-24 ニューヨーク・ブラッド・センター・インコーポレイテッド 血液型の変換方法
AU1298699A (en) 1997-11-03 1999-05-24 Curators Of The University Of Missouri, The Alpha-n-acetylgalactosaminidase from (clostridium perfringens)
US7767415B2 (en) * 2001-09-25 2010-08-03 Velico Medical, Inc. Compositions and methods for modifying blood cell carbohydrates

Also Published As

Publication number Publication date
WO2003027245A2 (en) 2003-04-03
JP4371810B2 (ja) 2009-11-25
US8697411B2 (en) 2014-04-15
US20120202273A1 (en) 2012-08-09
JP2009153525A (ja) 2009-07-16
AU2008203095B2 (en) 2012-02-02
US20050208655A1 (en) 2005-09-22
EP1436387A4 (de) 2005-12-21
JP2005503808A (ja) 2005-02-10
CA2460575C (en) 2013-07-30
US20140220553A1 (en) 2014-08-07
CA2460575A1 (en) 2003-04-03
US7993896B2 (en) 2011-08-09
US20030157474A1 (en) 2003-08-21
WO2003027245B1 (en) 2003-08-21
EP2302045A1 (de) 2011-03-30
EP1436387A2 (de) 2004-07-14
AU2008203095A1 (en) 2010-03-18
US20110045569A1 (en) 2011-02-24
US7767415B2 (en) 2010-08-03
WO2003027245A3 (en) 2003-07-10
EP1436387B1 (de) 2011-07-27

Similar Documents

Publication Publication Date Title
ATE517986T1 (de) Enzymatische umwandlung von roten blutzellen der blutgruppen b und ab unter verwendung von einem alpha-galactosidase mit einzigartigen substratspezifitäten und kinetischen eigenschaften
BR0010989A (pt) Plantas e células de plantas geneticamente modificadas com uma atividade aumentada de uma proteìna de amilossacarase e uma enzima de ramificação
DK1022329T3 (da) Multienzymatisk sammensætning med glucoamylasisk, proteolytisk og xylanasisk aktivitet samt fremgangsmåde til fremstilling af sammensætningen ved hjælp af aspergillus-gæring i et fast hvedeklidsmedium
EP1498485A4 (de) Zellen mit modifiziertem genom
IT1190780B (it) Prodotto enzimatico deramificante,sua preparazione ed uso
WO2004044158A3 (en) Human embryonic stem cell cultures, and compositions and methods for growing same
DE69333067D1 (de) Enzym mit endoglukanase wirkung
WO2003010302A1 (fr) Construction cellulaire cultivee contenant des spheroides de cellules animales cultivees et utilisation correspondante
EP0227264A3 (de) Transformation und Fremdgenexpression mit holzigen Arten
NZ512185A (en) A method for manufacturing glycoproteins having human- type glycosylation in plant cells
WO2003091431A8 (fr) Methylotrophe produisant une chaine de sucre de type mammifere
WO1995010616A3 (en) USE OF α-1,4-GLUCAN LYASE FOR PREPARATION OF 1,5-D-ANHYDROFRUCTOSE
WO2000015764A3 (en) Propagation and/or derivation of embryonic stem cells
WO2003054160A3 (en) Cell lines with latent immunodeficiency virus and methods of use thereof
CA2154944A1 (en) Thermostable xylanase dna, protein and methods of use
CA2219962A1 (en) C3 plants expressing photosynthetic enzyme of c4 plants
MXPA02006094A (es) Metodos para producir embriones clonadod y adultos a partir de celulas cultivadas.
EP0807685A3 (de) Saccharose-Phosphate-Synthase (SPS), Verfahren zu ihrer Herstellung, ihre cDNA und deren Verwendung von die Expressionsrate von SPS in pflanzlichen Zellen zu verändern
CA2119070A1 (en) Energy-supplementing saccharide source and its uses
WO2002058588A3 (en) Processes for making cryopreserved composite living constructs and products resulting therefrom
EP0841397A3 (de) Trehalose phosphorylase, deren Herstellung und Verwendung
AU3609800A (en) Novel formulations of alkyllithiums with improved thermal stability, processes to produce these formulations and processes for using the same to improve stability of living polymer chain ends
WO2000001841A3 (en) Hyaluronic acid mimics and methods related thereto
WO2002034902A3 (en) Reversibly soluble enzyme-polymer conjugates
WO1993023529A3 (fr) Culture stabilisee d'agregats cellulaires et procede de developpement des embryons a partir d'une souche proembryogene destine a la regeneration de la vigne

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties